Walking exercise for metabolic syndrome and fatty liver in girls with celiac disease
Tests walking exercise in teenage girls with celiac disease, metabolic syndrome and fatty liver.
Plain-language title generated from the registry record
Registry title: Metaboic Syndrome and Fatty Liver in Celiac Disease Females: Reponse to Exercise in Adolescents
Key facts
- Where
- Giza, EgyptSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adolescent girls with celiac disease who also have metabolic syndrome and fatty liver. It tests whether walking exercise helps.
- Age
- 13 to 17 years
- Sex
- Females only
- Disease stage
- Celiac disease together with metabolic syndrome and nonalcoholic fatty liver
Main reasons for not taking part
- Heart disease
- Kidney failure
- Lung or breathing disease
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 13 and 17 years old?
Source: NCT07832994, who can take part
Where in Egypt
- Cairo UniversityGiza, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Cairo University
- Trial code
- NCT07832994
- Record updated
- 22 September 2026
- Original description
metabolic syndrome and fatty liver is common in adolescents with celiac diseases. exercise may control these cardiovascular risk factorsRead full original descriptionShow less
Metaboic Syndrome and Fatty Liver in Celiac Disease Females: Reponse to Exercise in Adolescents
metabolic syndrome and fatty liver is common in adolescents with celiac diseases. exercise may control these cardiovascular risk factors
Inclusion: celiac disease; metabolic syndrome; nonalcholic fatty liver.
Exclusion: cardiac disease; renal failure; respiratory disease.